These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


96 related items for PubMed ID: 395710

  • 21. [Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients].
    Yamanaka H, Yuasa H, Natori E, Imai K, Mashimo T.
    Rinsho Byori; 1987 Oct; 35(10):1154-8. PubMed ID: 3325662
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. An unusual increase in prostatic acid phosphatase not associated with prostatic cancer.
    Barracchia A, Vecce R, Lari R.
    Haematologica; 1988 Oct; 73(3):249. PubMed ID: 3139523
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Value of commercial enzyme immunoassays in the determination of prostatic acid phosphatase].
    Rassweiler J, Lutz K, Müller HA, Eisenberger F.
    Urologe A; 1988 Jan; 27(1):32-5. PubMed ID: 2452506
    [Abstract] [Full Text] [Related]

  • 26. Isoenzymes of alkaline phosphatase in serum of patients with prostatic cancer.
    Røhl H, Jørgensen PJ, Hørder M.
    Scand J Clin Lab Invest Suppl; 1985 Jan; 179():101-5. PubMed ID: 3866302
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Evaluation of 2 methods of determining prostatic acid phosphatase].
    Venturini M, Calafati P, De Grandi R, Pescatore D, Varaldo M, Natta G.
    Arch Maragliano Patol Clin; 1980 Jan; 36():35-41. PubMed ID: 6178374
    [No Abstract] [Full Text] [Related]

  • 32. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
    Ogawa A, Yoshida A, Kanda T, Sugihara S, Suzuki T, Tamura J, Kobayashi I, Nakazato Y.
    J Med; 2000 Jan; 31(1-2):101-10. PubMed ID: 10998759
    [Abstract] [Full Text] [Related]

  • 33. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS, Habig H, Crüsemann D.
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J, de Torres Mateos JA, Soler-Roselló A.
    Actas Urol Esp; 1988 Sep; 12(2):152-7. PubMed ID: 2458015
    [No Abstract] [Full Text] [Related]

  • 36. Clinical applications of various methodologies for measuring S-acid phosphatases. An inquiry by the Scandinavian Prostatic Cancer Group (SPCG).
    Rasmussen F.
    Scand J Clin Lab Invest Suppl; 1985 Sep; 179():19-24. PubMed ID: 3866305
    [No Abstract] [Full Text] [Related]

  • 37. [Experience with prostate-specific antigen in patients with prostatic cancer].
    Romics I, Bach D.
    Orv Hetil; 1989 Dec 24; 130(52):2797-800. PubMed ID: 2481833
    [Abstract] [Full Text] [Related]

  • 38. The radioimmunochemical measurement of prostatic acid phosphatase: current state of the art.
    Cooper JF.
    Urol Clin North Am; 1980 Oct 24; 7(3):653-65. PubMed ID: 6161460
    [Abstract] [Full Text] [Related]

  • 39. Immunologic markers and the diagnosis of prostatic cancer.
    Ban Y, Wang MC, Chu TM.
    Urol Clin North Am; 1984 May 24; 11(2):269-76. PubMed ID: 6203206
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.